GDSTX
Price
$30.91
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VSCIX
Price
$119.32
Change
-$1.38 (-1.14%)
Updated
Nov 14 closing price
Ad is loading...

GDSTX vs VSCIX

Header iconGDSTX vs VSCIX Comparison
Open Charts GDSTX vs VSCIXBanner chart's image
Goldman Sachs Small Cap Eq Insghts I
Price$30.91
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$119.32
Change-$1.38 (-1.14%)
VolumeN/A
CapitalizationN/A
GDSTX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GDSTX vs. VSCIX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDSTX is a Buy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. GDSTX (473M). VSCIX pays higher dividends than GDSTX: VSCIX (1.43) vs GDSTX (0.64). GDSTX was incepted earlier than VSCIX: GDSTX (17 years) vs VSCIX (27 years). GDSTX is a more actively managed with annual turnover of: 145.00 vs. VSCIX (12.00). GDSTX has a lower initial minimum investment than VSCIX: GDSTX (0) vs VSCIX (5000000). GDSTX annual gain was more profitable for investors over the last year : 40.54 vs. VSCIX (32.13). VSCIX return over 5 years is better than : 59.15 vs. GDSTX (21.81).
GDSTXVSCIXGDSTX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years27 years-
Gain YTD26.58818.404144%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets473M151B0%
Annual Yield % from dividends0.641.4345%
Returns for 1 year40.5432.13126%
Returns for 3 years-14.477.14-203%
Returns for 5 years21.8159.1537%
Returns for 10 years75.31128.6359%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS20.150.31
+1.56%
Pharvaris NV
BOX34.670.43
+1.26%
BOX
TSCO278.75-0.44
-0.16%
Tractor Supply Company
XGN2.75-0.04
-1.43%
Exagen
AMTX4.11-0.51
-11.04%
Aemetis